These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3079310)

  • 1. An NMR blood test for cancer: a critical assessment.
    Chmurny GN; Hilton BD; Halverson D; McGregor GN; Klose J; Issaq HJ; Muschik GM; Urba WJ; Mellini ML; Costello R
    NMR Biomed; 1988 Jun; 1(3):136-50. PubMed ID: 3079310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tumor detection in serum by NMR spectrometry. A critical evaluation of the so-called Fossel test].
    Schalk KP; Rüterjans H; Kaltwasser JP; Said l-Hadj H; Staffenberger L
    Onkologie; 1989 Aug; 12 Suppl 1():5-8. PubMed ID: 2685697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperlipidemia as a biochemical basis of magnetic resonance plasma test for cancer.
    Holmes KT; Mackinnon WB; May GL; Wright LC; Dyne M; Tattersall MH; Mountford CE; Sullivan D
    NMR Biomed; 1988 Feb; 1(1):44-9. PubMed ID: 3275022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some factors that influence the plasma lipoprotein 1H NMR spectra of normal and cancer patients: an oncolipid test?
    Lim HM; Price TB; Marsh JC; Rainey PM; Gore JC; Armitage IM
    Yale J Biol Med; 1991; 64(1):63-77. PubMed ID: 1897263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An improved method for the detection of malignancy by proton NMR spectroscopy of plasma.
    Otvos JD; Coffer MC; Chen SM; Wehrli S
    Biochem Biophys Res Commun; 1987 Jun; 145(3):1397-403. PubMed ID: 3606609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of malignant tumors: water-suppressed proton nuclear magnetic resonance spectroscopy of plasma.
    Dowd TL; Kaplan BA; Gupta RK; Aisen P
    Magn Reson Med; 1987 Oct; 5(4):395-7. PubMed ID: 3683172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modification of the relative plasma concentrations of methyl and methylene groups in cancer: a study using proton NMR spectroscopy].
    Vion-Dury J; Sciaky M; Confort-Gouny S; Kriat M; Favre R; Grisoli F; Harlé JR; Fontanarava E; Mongin M; Carcassonne Y
    C R Acad Sci III; 1989; 309(10):415-8. PubMed ID: 2514967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the value of identifying the presence of malignant disease in human plasma by proton nuclear magnetic resonance spectroscopy.
    Buchthal SD; Hardy MA; Brown TR
    Am J Med; 1988 Oct; 85(4):528-32. PubMed ID: 3177400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton NMR spectroscopy of plasma lipoproteins: a marker of the immune function in cancer disease?
    Leray G; de Certaines JD
    Anticancer Res; 1994; 14(5A):1839-51. PubMed ID: 7847817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of efficacy of water-suppressed proton nuclear magnetic resonance spectroscopy of plasma for the detection of malignant tumors.
    Okunieff P; Zietman A; Kahn J; Singer S; Neuringer LJ; Levine RA; Evans FE
    N Engl J Med; 1990 Apr; 322(14):953-8. PubMed ID: 2314447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [H-NMR spectroscopy of plasma cannot be used for cancer screening].
    Tran Dinh S; Schlumberger M; Gicquel C; Neumann JM; Hervé M; Turpin G; Parmentier C
    Bull Cancer; 1988; 75(8):795-800. PubMed ID: 3179513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of proton nuclear magnetic resonance spectroscopy for detection of malignancy.
    Wilding P; Senior MB; Inubushi T; Ludwick ML
    Clin Chem; 1988 Mar; 34(3):505-11. PubMed ID: 3349601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance spectroscopy of blood plasma lipoproteins in malignant disease: methodological aspects and clinical relevance.
    Engan T
    Anticancer Res; 1996; 16(3B):1461-71. PubMed ID: 8694514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The proton NMR of blood plasma and the test for cancer.
    Herring FG; Phillips PS; Pritchard H; Silver H; Whittal KP
    Magn Reson Med; 1990 Oct; 16(1):35-48. PubMed ID: 2175009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [NMR research on blood plasma for tumor detection--a method for mass screening?].
    Fritzsche H; Sprinz H; Jahn H; Jorke D
    Arch Geschwulstforsch; 1989; 59(2):129-33. PubMed ID: 2719533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton magnetic resonance spectroscopy of fractionated plasma lipoproteins and reconstituted plasma from healthy subjects and patients with cancer.
    Engan T; Bjerve KS; Høe AL; Krane J
    Scand J Clin Lab Invest; 1992 Sep; 52(5):393-408. PubMed ID: 1514018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oral contraception on water-suppressed proton NMR spectra of plasma.
    Carlier PG; Vaesen F; Gilles RG; Fradin EA; Rorive GL
    Magn Reson Med; 1991 Jan; 17(1):269-73. PubMed ID: 1648654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma.
    Fossel ET; Carr JM; McDonagh J
    N Engl J Med; 1986 Nov; 315(22):1369-76. PubMed ID: 3022146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton nuclear magnetic resonance lineshape studies on human blood plasma lipids from newborn infants, healthy adults, and adults with tumors.
    Hiltunen Y; Ala-Korpela M; Jokisaari J; Eskelinen S; Kiviniitty K
    Magn Reson Med; 1992 Jul; 26(1):89-99. PubMed ID: 1625571
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.